Condition: Recurrent Nasopharyngeal Carcinoma · Sponsor: Guangzhou Concord Cancer Center
The above studies show that most of the supportive evidence for the reduction of toxicity and improvement of efficacy of proton therapy for recurrent Nasopharyngeal carcinoma(NPC) comes from various observational and retrospective studies, lacking high-level evidence-based medical evidence. The conduct of this study will explore the safety and efficacy of intensity-modulated proton radiotherapy for recurrent NPC and provide more high-quality evidence-based medical evidence for proton therapy of recurrent cancer.
This description comes directly from the study's public registry record.
Taize Yuan, M.D., Ph.D. · 8620-32506195 · taize.yuan@ccm.cn
Always discuss trial participation with your own doctor first.
| Guangzhou Concord Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Guangzhou concord cancer center | Guanzhou, Guangzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07412314